By BY MATT RICHTEL from NYT Health
https://ift.tt/Sp04GUA
At the urging of the federal government, Pfizer and its partner BioNTech applied last week for authorization for two doses of its Covid vaccine to children aged 4 and younger.
Omicron’s surge helped clarify the Pfizer vaccine’s efficacy in young children, a company board member says.
By BY MATT RICHTEL from NYT Health
https://ift.tt/Sp04GUA
At the urging of the federal government, Pfizer and its partner BioNTech applied last week for authorization for two doses of its Covid vaccine to children aged 4 and younger.
No comments:
Post a Comment